当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第35期
编号:13207380
胶质母细胞瘤治疗现状和化疗药物研究进展(4)
http://www.100md.com 2017年12月15日 中国医药导报 2017年第35期
     [16] Pais V,Danaila L,Pais E,et al. Ultrastructural patterns of the activated cell death programs in the human brain [J]. Ultrastruct,2013,37(2):110-120.

    [17] Valle B,Gómez D,Nieto-Sampedro M,et al. Synthesis and characterization of neurostatin-related compounds with high inhibitory activity of glioma growth [J]. Eur J Med Chem,2010,45(5):2034-2043.

    [18] Nieto M,Broderick JT. A soluble brain molecule related to epidermal growth factor receptor is a mitogen inhibitor for astrocytes [J]. J Neurosci,1989,22(1):28-35.

    [19] Kaufmann JK,Chiocca EA. Glioma virus therapies between bench and bedside [J]. Neuro Oncol,2014,16(3):334-351.

    [20] Murphy AM,Rabkin SD. Current status of gene therapy for brain tumors [J]. Transl Res,2013,161(4):339-354.

    [21] Swinnen JV,Roskams T,Joniau S,et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer [J]. Int J Cancer,2002,98(1):19-22.

    [22] Kuhajda FP. Fatty acid synthase and cancer:new application of an old pathway [J]. Cancer Res,2006,66(12):5977-5980.

    [23] Jiang P,Mukthavaram R,Chao Y,et al. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs [J]. J Transl Med,2014, 22(12):12-13.

    (收稿日期:2017-09-03 本文編辑:张瑜杰), http://www.100md.com(黄书岚 刘宇航 王辉)
上一页1 2 3 4